trial · primary record
[18F]PI-2620
Alzheimer Disease
| Phase | Phase 3 |
|---|---|
| Status | RECRUITING |
| Sponsor | Unknown |
| Enrolment | 200 |
| Primary completion | 2028-09 |
| Primary endpoint | Diagnostic Efficacy of the visual assessment of [18F]PI-2620 PET imaging, in correctly differentiating tau neurofibrillary pathology associated with AD (NFT Score of B0 or B1 = negative) |
| Registry ID | NCT05641688 |
Provenance
- Source: ClinicalTrials.gov
- Fetched at: 2026-10-28T02:33:11.748Z
- Licence class: attribution-required
- Verdict: primary-source
- Entity id: NCT05641688
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.